Clinical Trial Update: A Pilot Study of Creatine Monohydrate as an Augmenting Agent for ECT in Persons With Major Depressive Disorder [Phase 3]

View source ↗

Summary

Phase 3 pilot study evaluating creatine monohydrate as an augmenting agent to electroconvulsive therapy in adults with Major Depressive Disorder; results have b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Creatine monohydrate (creatine monohydrate)

Snippet

Sponsor: University of Utah | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2024-11-26